Communiqués MindMaze Therapeutics Holding SA

Actions

RLF

CH1251125998

Recherche biotechnologique et médicale

Marché Fermé - Swiss Exchange 17:31:22 14/08/2026			Varia. 5j.	Varia. 1 janv.
0,2290 ^CHF	-2,14%		-4,98%	-87,95%

10/08	Bourse Zurich: dans le vert pour entamer la semaine	AW
10/08	Mindmaze finalise sa restructuration et met à jour son financement	AW

Communiqués

12/08	MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor	EQ
10/08	MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing	EQ
09/07	MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy	EQ
01/07	MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe	EQ
25/06	MindMaze Therapeutics Announces Results of Annual General Meeting	EQ
03/06	MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting	PR
03/06	MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting	EQ
03/06	MindMaze Therapeutics : AGM invitation 2026 EN	PU
02/06	MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification	EQ
26/05	MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing	EQ
12/05	MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.	EQ
30/04	MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.	EQ
15/04	MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update	EQ
31/03	MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation	EQ
19/03	MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank	AQ
19/03	MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank	EQ
19/03	MindMaze Therapeutics : Announces Initiation of Coverage by Baader Bank	PU
12/03	MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale	BU
12/03	MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale	EQ
12/03	MindMaze Therapeutics : Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale	PU
03/03	MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation	EQ
03/03	MindMaze Therapeutics : investor presentation – March 2026	PU
23/12	MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics	EQ
15/12	Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics	EQ
25/11	Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination	EQ